American Sleep Apnea Association

Nancy H. Rothstein The Sleep Ambassador Joins Hapbee as Strategic Advisor

Retrieved on: 
Thursday, November 2, 2023
Well, Scholastic, Sleep, American Sleep Apnea Association, Organization, MBA, Committee, Digital technology, Superpower, Function (mathematics), Executive Committee, FSE, Procter & Gamble, HA1, Mental health, Pharmaceutical industry

VANCOUVER, BC, Nov. 2, 2023 /PRNewswire/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company") is pleased to announce that Nancy H. Rothstein, MBA, The Sleep Ambassador®, is joining as a strategic adviser who will help guide enhancements to and foster empirical validation of Hapbee's industry-leading sleep solutions.

Key Points: 
  • VANCOUVER, BC, Nov. 2, 2023 /PRNewswire/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company") is pleased to announce that Nancy H. Rothstein, MBA, The Sleep Ambassador®, is joining as a strategic adviser who will help guide enhancements to and foster empirical validation of Hapbee's industry-leading sleep solutions.
  • Her book, My Daddy Snores (Scholastic), has sold over 550,000 copies and her online sleep course for LinkedIn Learning- Sleep Is Your Superpower - has been taken by over 450,000 globally.
  • Nancy created the Sleep Well/Live Well sleep improvement program which has engaged thousands of employees and is now available to the public.
  • "Attracting a professional with Nancy's pedigree and stellar reputation as a sleep expert represents a major validation for Hapbee," said Yona Shtern, CEO of Hapbee.

Sunshine Dentistry Named Best of Jersey Shore Dentist, Cosmetic Dentist, and Pediatric Dentist for 2022

Retrieved on: 
Tuesday, January 17, 2023
Dental care, Academy of General Dentistry, University, Tufts University School of Dental Medicine, American Sleep Apnea Association, Anzac of the Year Award, Postgraduate training in general dentistry, Sleep apnea, Friends, Health, Tufts University, DMD, Villanova University, UMMA Community Clinic, Patient, HOUSE, Indian Army Dental Corps, Fellow, American Academy, Science, Pennsylvania State University, Veteran, Heart, Life, Temporomandibular joint dysfunction, Sleep, Dentistry, TMJ, Pediatric dentistry

CAPE MAY COURT HOUSE, N.J., Jan. 17, 2023 /PRNewswire-PRWeb/ -- Sunshine Dentistry has been named a 2022 Best of Jersey Shore business in the fields of Dentistry, Cosmetic Dentistry, and Pediatric Dentistry. Sunshine Dentistry is an all-age dental practice that provides lifelong care for patients beginning with a child's first dental exam. The practice offers preventative care, restorative care, pediatric care, cosmetic dental treatments, treatment for TMJ disorders, and treatment for sleep disorders including sleep apnea.

Key Points: 
  • Sunshine Dentistry has been named a 2022 Best of Jersey Shore business in the fields of Dentistry, Cosmetic Dentistry, and Pediatric Dentistry.
  • CAPE MAY COURT HOUSE, N.J., Jan. 17, 2023 /PRNewswire-PRWeb/ -- Sunshine Dentistry has been named a 2022 Best of Jersey Shore business in the fields of Dentistry, Cosmetic Dentistry, and Pediatric Dentistry.
  • "We're very honored to earn this flattering recognition," said Owner Dr. Eric V. Thomas, who launched Sunshine Dentistry in 1996.
  • Dr. Thomas has previously been named a Top Doctor in New Jersey, in the field of Dentistry.

Worldwide Sleep Apnea Implant Industry to 2027 - North America is Expected to Hold a Significant Share in the Market - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 27, 2022
Men, Other Health, General Health, Consumer, Technology, Medical Devices, Hospitals, Surgery, Women, Medical Supplies, Seniors, Other Technology, Health, CPAP, Awareness, Sleep, Association, Obstructive sleep apnea, Patient, American Sleep Apnea Association, Inspiration, Prevalence, Growth, OSA, ResMed, Adoption, CAGR, Continuous positive airway pressure, Sleep apnea, Insurance, Obesity, Central sleep apnea, Snoring, Medical device, Pharmaceutical industry

These implants are used for the treatment of sleep disorders, like obstructive sleep apnea and central sleep apnea.

Key Points: 
  • These implants are used for the treatment of sleep disorders, like obstructive sleep apnea and central sleep apnea.
  • The growth of the sleep apnea implants market can be attributed to factors, such as the large pool of undiagnosed sleep apnea patients and growing awareness about the ill effects of untreated sleep apnea.
  • Moreover, with the increasing obesity worldwide, the sleep apnea patient pool is also expected to grow in forecasted period, which further may increase the chances of adopting sleep apnea implants.
  • North America expected to hold a major market share in the global sleep apnea implant market owing to factors such as rising prevalence of sleep apnea in the region, increasing awareness, favourable reimbursement policies, government initiatives with growing funding.

Dr. Clifford Brown Announces Full-Time Transition to Sleep Practice

Retrieved on: 
Thursday, January 6, 2022
Time, Academy, American Sleep Apnea Association, Family, Dental care, Philips, Star Wars, COVID-19, Insomnia, Dentistry, Sleep apnea, Dentist, American Academy, Attention, Association, Health, Sleep, Patient, Silent Night, Cancer, Jaw, Mouth, Atmosphere, Hypertension, CPAP, Philosophy, OSA, Weight gain, New York State Route 27, OSAS, Death, Headache, Pharmaceutical industry, Medical device

Dr. Brown is a member of the American Academy of Dental Sleep Medicine (AADSM) and the Academy of Clinical Sleep Disorder Disciplines.

Key Points: 
  • Dr. Brown is a member of the American Academy of Dental Sleep Medicine (AADSM) and the Academy of Clinical Sleep Disorder Disciplines.
  • According to the American Sleep Apnea Association , it is estimated that 22 million Americans are currently living with sleep apnea.
  • Dr. Brown's sleep therapy practice, Silent Night Therapy, offers effective alternative solutions for sleep apnea patients.
  • A member of the American Academy of Dental Sleep Medicine (AADSM) and the Academy of Clinical Sleep Disorder Disciplines, Dr. Brown started Silent Night Therapy to better assist sleep apnea patients.

FDA Provides Update on Recall of Certain Philips Respironics Breathing Assistance Machines

Retrieved on: 
Friday, November 12, 2021
Quality of life, Safety, Federal Food, Drug, and Cosmetic Act, Record, Respironics, Organic compound, Health, Chronic obstructive pulmonary disease, Muscular Dystrophy Association, COPD, Center, American Sleep Apnea Association, Food, Continuous positive airway pressure, American Academy of Sleep Medicine, Muscular dystrophy, FDA Center for Devices and Radiological Health, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, American Academy, Patient, CPAP, Device, Mended Hearts, Review, Volatile organic compound, Marketing, FAQ, Risk, FDA, Non-invasive ventilation, Medical device

We are committed to continuing to regularly update the public about the status of this recall, including any new recommendations or actions regarding Philips Respironics' devices."

Key Points: 
  • We are committed to continuing to regularly update the public about the status of this recall, including any new recommendations or actions regarding Philips Respironics' devices."
  • Earlier this year, Philips Respironics initiated a recall of certain ventilators, CPAP and BiPAP machines due to potential health risks related to polyester-based polyurethane sound abatement foam used in the devices.
  • Following the initial recall, Philips Respironics developed a plan to repair the polyester-based polyurethane foam in the recalled CPAP and BiPAP devices with a different, silicone-based foam.
  • The FDA initially approved this plan based, in part, on testing the company provided to the FDA in June on the new foam.

Global Sleep Aid Markets, 2021-2027 - Focus on Insomnia, Sleep Apnea, Narcolepsy, Sleep Walking, Restless Legs Syndrome, Sleep Labs, Mattresses and Pillows, Medications, and Sleep Apnea Devices - ResearchAndMarkets.com

Retrieved on: 
Monday, September 20, 2021
Alternative Medicine, Pharmaceutical, Health, Dizziness, Sleep, Pillow, American Sleep Apnea Association, Ageing, Constipation, Narcolepsy, Association, Population, Sleep apnea, Growth, Awareness, Sleep disorder, Restless legs syndrome, COVID-19, OECD, Government, Diarrhea, Pharmaceutical industry, Health insurance

Global Sleep Aid Market Size, Share & Trends Analysis Report by Sleep Disorder (Insomnia, Sleep Apnea, Narcolepsy, Sleep Walking, and Restless Legs Syndrome), By Products (Sleep Laboratories, Specialty Mattresses and Pillows, Medications, and Sleep Apnea Devices) Forecast Period 2021-2027.

Key Points: 
  • Global Sleep Aid Market Size, Share & Trends Analysis Report by Sleep Disorder (Insomnia, Sleep Apnea, Narcolepsy, Sleep Walking, and Restless Legs Syndrome), By Products (Sleep Laboratories, Specialty Mattresses and Pillows, Medications, and Sleep Apnea Devices) Forecast Period 2021-2027.
  • The rising disposable income, and rise in awareness about sleep disorders, and easy availability of sleep aid devices, would generate new chances for the sleep aid market during the forecasted period.
  • Medication, sleep apneas devices, sleep laboratories, and mattresses and pillows, among others, are types of sleep aids.
  • Due to the re-launches of the sleep devices by the major players the market will recover rapidly during the forecast period.

Sleep Apnea Devices Market Size Worth $6.1 Billion By 2028 | CAGR: 6.2%: Grand View Research, Inc.

Retrieved on: 
Monday, April 12, 2021
Branches of biology, Sleep disorders, Clinical medicine, Medicine, Sleep apnea, Apnea, Fisher & Paykel, Sleep, American Sleep Apnea Association

b'SAN FRANCISCO, April 12, 2021 /PRNewswire/ -- The global sleep apnea devices market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • b'SAN FRANCISCO, April 12, 2021 /PRNewswire/ -- The global sleep apnea devices market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc.
  • Obesity is a major factor in sleep apnea.
  • In February 2020, Fisher and Paykel launched F&P Evora with CapFit headgear, a compact nasal mask for treating sleep apnea.
  • The company launched this product in the markets of New Zealand, Europe, Australia, and Canada.\nGrand View Research has segmented the global sleep apnea devices market on the basis of product type and region:\nSleep Apnea Devices Product Type Outlook (Revenue, USD Million, 2016 - 2028)\n'

Sleep Apnea Devices Market Size Worth $6.1 Billion By 2028 | CAGR: 6.2%: Grand View Research, Inc.

Retrieved on: 
Monday, April 12, 2021
Branches of biology, Sleep disorders, Clinical medicine, Medicine, Sleep apnea, Apnea, Fisher & Paykel, Sleep, American Sleep Apnea Association

b'SAN FRANCISCO, April 12, 2021 /PRNewswire/ -- The global sleep apnea devices market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc.

Key Points: 
  • b'SAN FRANCISCO, April 12, 2021 /PRNewswire/ -- The global sleep apnea devices market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc.
  • Obesity is a major factor in sleep apnea.
  • In February 2020, Fisher and Paykel launched F&P Evora with CapFit headgear, a compact nasal mask for treating sleep apnea.
  • The company launched this product in the markets of New Zealand, Europe, Australia, and Canada.\nGrand View Research has segmented the global sleep apnea devices market on the basis of product type and region:\nSleep Apnea Devices Product Type Outlook (Revenue, USD Million, 2016 - 2028)\n'

Apnimed Strengthens Management Team with Addition of Leading Sleep Medicine Expert, David P. White, M.D.

Retrieved on: 
Thursday, March 4, 2021
Pharmaceutical, Health, Clinical trials, Medical devices, Branches of biology, Sleep disorders, Biology, Neurophysiology, Dream, Sleep medicine, Sleep apnea, Respironics, American Academy of Sleep Medicine, Sleep, European Sleep Apnea Database, American Sleep Apnea Association, Obstructive Sleep Apnea, Apnimed

Dr. White is a world-renowned leader in sleep disorders having served as President of the American Academy of Sleep Medicine, and recently as the Chief Medical Officer for Philips Respironics.

Key Points: 
  • Dr. White is a world-renowned leader in sleep disorders having served as President of the American Academy of Sleep Medicine, and recently as the Chief Medical Officer for Philips Respironics.
  • Sleep apnea can importantly impact the health and well-being of patients and result in life threatening consequences; thus, patients need improved therapeutic options.
  • In addition to his new position at Apnimed, Dr. White is a Professor of Medicine, part-time, at Harvard Medical School in Boston, Mass.
  • He also chaired the task force that wrote the research plan to address sleep and sleep disorders for the National Institutes of Health.

Worldwide Wearable Sleep Trackers Industry to 2025 - North America Dominates the Market - ResearchAndMarkets.com

Retrieved on: 
Friday, August 14, 2020
Retail, Consumer electronics, Health, Technology, Fitness & Nutrition, Specialty, Sleep disorders, Branches of biology, Animal physiology, Clinical medicine, Sleep apnea, Sleep, Apnea, Central sleep apnea, American Sleep Apnea Association

Apart from the advantages of the wrist bands, the factors boosting the market are the increasing patient pool of sleep disorders.

Key Points: 
  • Apart from the advantages of the wrist bands, the factors boosting the market are the increasing patient pool of sleep disorders.
  • According to the Sleep Apnea Organization, in 2017, more than 22 million Americans suffered from sleep apnea and 80% of moderate to severe sleep apnea cases were undiagnosed; worldwide, over 100 million people suffer from sleep apnea.
  • Thus, the increasing incidence of sleep apnea is one of the factors responsible for the growth of the market.
  • North America is expected to dominate the overall Wearable Sleep Trackers market, throughout the forecast period.